Načítá se...

Severe Hypocalcemia and Dramatic Increase in Parathyroid Hormone after Denosumab in a Dialysis Patient: A Case Report and Review of the Literature

Chronic kidney disease-mineral and bone disorder (CKD-MBD) is frequently present in advanced stages of chronic kidney disease (CKD) patients with high risk of fracture and elevated socioeconomic burden. Denosumab, an injectable human monoclonal antibody with affinity for nuclear factor-kappa ligand...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Nephrol
Hlavní autoři: Bhanot, Ravinder D., Kaur, Jasleen, Bhat, Zeenat
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6448326/
https://ncbi.nlm.nih.gov/pubmed/31016056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3027419
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!